Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_assertion type Assertion NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_head.
- NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_assertion wasGeneratedBy ECO_0000203 NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_provenance.
- NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_assertion wasDerivedFrom befree-2016 NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_provenance.
- NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_assertion SIO_000772 11840259 NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_provenance.
- NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_assertion evidence source_evidence_literature NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_provenance.
- NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_assertion description "[Multivariate COX regression analysis adjusted for chemotherapy protocol, de novo vs secondary AML, and de novo vs relapsed AML indicated: (1) At diagnosis, high expression of Bad (P = 0.015) and even more so high Bax and Bad levels (P = 0.018) predicted adverse outcome, regardless of the response to ICT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344787.RA7r87w58u4u16S4K3NlfVxtclrlUBkNjAFbmqp1YhVoA130_provenance.